Koa Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.38M Buy
94,333
+511
+0.5% +$34.8K 5.02% 5
2026
Q1
$6.06M Buy
93,822
+714
+0.8% +$50.3K 4.38% 5
2025
Q4
$6.27M Buy
93,108
+6,465
+7% +$435K 4.3% 5
2025
Q3
$6.35M Sell
86,643
-3,878
-4% -$258K 4.71% 4
2025
Q2
$4.71M Buy
90,521
+5,043
+6% +$287K 3.74% 6
2025
Q1
$5.45M Buy
85,478
+3,071
+4% +$178K 4.4% 5
2024
Q4
$3.94M Buy
82,407
+7,924
+11% +$406K 3.22% 6
2024
Q3
$4.26M Buy
74,483
+915
+1% +$52.5K 3.29% 8
2024
Q2
$3.85M Sell
73,568
-848
-1% -$37.2K 3.26% 8
2024
Q1
$3.03M Buy
74,416
+9,503
+15% +$356K 2.73% 11
2023
Q4
$2.4M Buy
+64,913
New +$2.44M 2.37% 14

Other funds holding HALO

Koa Wealth Management's HALO Position: Q2 2026 in Review

Koa Wealth Management increased its Halozyme (HALO) stake by 0.54% in Q2 2026, buying an estimated $34.8K and bringing the position to 94,333 shares worth $7.38M. The position accounts for 5.02% of the portfolio, ranked #5.

Koa Wealth Management first reported a position in HALO in Q4 2023 and has held it in 11 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Koa Wealth Management held 94,333 shares of Halozyme worth $7.38M as of Q2 2026.
  • Koa Wealth Management bought 511 Halozyme shares in Q2 2026, an estimated $34.8K.
  • Halozyme made up 5.02% of Koa Wealth Management's portfolio in Q2 2026, its #5 holding.
  • Koa Wealth Management first reported a position in Halozyme in Q4 2023 and has held it in 11 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Koa Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.